We serve Chemical Name:2,2′,3,3′,4,5,5′-Heptachlorobiphenyl CAS:52663-74-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2,2′,3,3′,4,5,5′-Heptachlorobiphenyl
CAS.NO:52663-74-8
Synonyms:1,2,3,4-tetrachloro-5-(2,3,5-trichlorophenyl)benzene
Molecular Formula:C12H3Cl7
Molecular Weight:395.32300
HS Code:2903999090
Physical and Chemical Properties:
Melting point:131.31°C (estimate)
Boiling point:427.2ºC at 760mmHg
Density:1.658g/cm3
Index of Refraction:1.632
PSA:
Exact Mass:391.80500
LogP:7.92740
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1,2,3,4-tetrachloro-5-(2,3,5-trichlorophenyl)benzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,2,3,4-tetrachloro-5-(2,3,5-trichlorophenyl)benzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,2,3,4-tetrachloro-5-(2,3,5-trichlorophenyl)benzene Use and application,1,2,3,4-tetrachloro-5-(2,3,5-trichlorophenyl)benzene technical grade,usp/ep/jp grade.
Related News: Among them, Zhejiang pharmaceutical companies accounted for 4 of the world’s top ten API manufacturers. 2,2′,3,3′,4,5,5′-Heptachlorobiphenyl manufacturer Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL. 2,2′,3,3′,4,5,5′-Heptachlorobiphenyl supplier The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma��s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution. 2,2′,3,3′,4,5,5′-Heptachlorobiphenyl vendor Green Valley said it would launch the drug ��very soon�� in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug. 2,2′,3,3′,4,5,5′-Heptachlorobiphenyl factory Green Valley said it would launch the drug ��very soon�� in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug.
